
Nucleai
@nucleai_ai
Followers
232
Following
236
Media
478
Statuses
654
Revolutionizing precision medicine through AI-powered spatial biology. Improving drug development, clinical decisions, and patient outcomes.
Israel / USA
Joined October 2020
In honor of Cancer #Immunotherapy Month, we're highlighting recent research that explores how AI-powered #spatialbiomarkers can help uncover insights into the TME and support a better understanding of treatment response and resistance.#immune2cancer
0
0
0
Missed our latest #NucleaiAcademy with Dr. Ken Bloom?.Watch on demand to explore how OD-based scoring and spatial analysis support ADC development. 📺 Watch the recording: #biomarkers #precisionmedicine #spatialbiomarkers #aipathology #digitalpathology
0
0
0
📢This coming Monday, join Dr. Ken Bloom as he explores the challenges of patient selection for ADCs—and how OD-based #biomarker scoring and computational pathology can provide deeper insights into target expression and drug activity.🔗#NucleaiAcademy
0
0
0
One week to go! 🎓 Join Dr. Ken Bloom on June 16 for a live #NucleaiAcademy #webinar exploring how OD-based quantitative #biomarker scoring and spatial analysis can support ADC drug development. 📅 Monday, June 16 | 11:00 AM ET. RSVP ➡️.
0
0
0
Closing out an incredible week at #ASCO25! Thank you to everyone who stopped by, shared insights, or joined the conversation. Couldn’t make it to Chicago? We’re offering virtual live demos of our ADC solution suite → #SpatialBiomarkers #DigitalPathology
0
0
2
Our #ASCO2025 poster is now live! In collaboration with @lunaphoreand Dr. Paolo A. Ascierto, we present new data using mIF + AI-powered spatial analysis to uncover tumor microenvironment features linked to #immunotherapy response. đź“„ #SpatialBiomarkers
0
0
1
Missed our poster session today? In collaboration with @lunaphore and Dr. Paolo A. Ascierto, we presented new data on predictive #SpatialBiomarkers in #melanoma. Visit our booth to learn more! .#ASCO25
0
1
0
It’s showtime! 🎬.We’re all set at ASCO 2025 — stop by Booth IH02 for live demos of our ADC solution suite. #ADCDevelopment #SpatialBiomarkers #AIPathology #DigitalPathology #PrecisionOncology #ASCO25
0
1
1
📢 Our #ASCO25 abstract is now live - developed in collaboration with @lunaphore and Dr. Paolo Ascierto, we present new data on predictive #SpatialBiomarkers in #melanoma. Poster #9524 | June 1 | 9–12 CT.📍 Booth IH02 | Melanoma Session.👉
0
0
0
Our ADC Suite of Solutions helps bridge the gap from correlation to causality, delivering clinically meaningful insights from complex data to support biomarker-informed trial design. The suite will be showcased at #ASCO25. Read the announcement →
0
0
0
📣📣 Just Announced: An Expanded Suite of ADC #AI #Biomarker Scoring Solutions. Book a demo at #ASCO25 to explore our ADC solution suite for biomarker-informed trial design. Read more → Book a demo → #spatialbiomarkers
0
0
0
#Spatialbiology is redefining disease research—moving beyond cell maps to uncover the interactions driving progression and resistance. Our Head of Pathology, Dr. Ken Bloom shares insights in the latest @NatureBiotech:.🔗 #spatialbiomarkers.
0
4
9
Live Nucleai Academy webinar 🎓: Learn how OD-based quantitative biomarker scoring can help derisk #ADC drug discovery and development. 📅 June 16 | 11 AM ET.🔗 #ADC #biomarkers #SpatialBiomarker #IHC #mIF #NucleaiAcademy
0
0
0
Thank you for joining us at @BiomedIsrael 2025!.Our CEO @Avi_ve moderated a powerful panel on turning #AI buzzwords into real-world #healthtech. Big thanks to the speakers from NVIDIA, AWS, AIVF, Eleos, Rounds, VIZ, AISAP & Laguna Health. #DigitalHealth #MedTech #BiomedIsrael25
0
0
0
Meet us at #ASCO25 to explore how AI spatial proteomics and OD-based quantitative scoring of IHC assays can help you derisk your #ADC programs. #spatialbiomarkers #PrecisionMedicine
0
0
0
That’s a wrap on Day 1 of @BiomedIsrael!.We’re just getting started—don’t miss our CEO & Co-founder, @avi_ve as he moderates tomorrow’s session: Wednesday, May 21 | 15:30 📍 Hall B.See you there! #medtech #AI #precisionmedicine #biotech
0
0
1
#AACR25 highlighted the need for better #biomarker strategies to guide the use of antibody-drug conjugates (#ADCs) and #immunotherapy. In our latest blog article, we discuss 3 key updates in #CancerResearch presented at the AACR 2025 conference ➡️
0
0
0
#ASCO25 is around the corner!.We're teaming up with @lunaphore and Dr. Paolo Ascierto to present new data on #SpatialBiomarkers in #melanoma. 📅 June 1 | 9–12 CT.📍 Booth IH02 – Live demos + more
0
0
0